Introduction {#s1}
============

*Staphylococcus aureus* is a complex human pathogen due to its ability to survive both as a carriage organism, and behave as an opportunistic pathogen in a susceptible host. It is a leading cause of invasive bacterial infection that contributes to substantial morbidity and mortality worldwide. This bacterium can cause a variety of diseases ranging from mild to severe skin and soft tissue infections, keratitis, and osteomyelitis to life-threatening bacteremia, pneumonia, endocarditis, and sepsis (Lowy, [@B25]; Rehm, [@B36]). Even though *S. aureus* colonizes human anterior nares and other sites on skin in 30--50% of the general population (Graham et al., [@B11]; Kuehnert et al., [@B23]; Gordon and Lowy, [@B9]), not everyone who is colonized gets infected. One reason could be differences in genetic susceptibility to colonization and infections. The established role of host susceptibility in other infectious diseases lends support for a role of host genetics in *S. aureus* infection (de Bakker and Telenti, [@B4]). Genetic susceptibility to *S. aureus* infections is expected to be complex because this pathogen uses a wide variety of virulence factors that interact with several host pathways to cause disease in humans.

Numerous alleles segregating at a large number of loci contribute to complex disease susceptibility (Yang et al., [@B43]) with contributions from both common and rare alleles. Because genetic risk factors for *S. aureus* infections have not been previously studied on a genome-wide scale, we utilized the Personalized Medicine Research Project (PMRP) of Marshfield Clinic---a large, population-based biobank of DNA samples---to perform a preliminary genome-wide association study (GWAS) of laboratory-confirmed *S. aureus* infections to discover the underlying host-pathogen interactions.

Materials and methods {#s2}
=====================

Subjects
--------

This study utilized Marshfield Clinic\'s PMRP biobank, a cohort of \~20,000 individuals from 14 Zip Codes surrounding Marshfield, Wisconsin, USA. DNA samples from 3234 PMRP participants were genotyped at \>500,000 SNPs as part of the NHGRI/NIGMS-funded eMERGE network (McCarty et al., [@B26]). These genotypic data are linked to longitudinal electronic medical records (EMR) at the Marshfield Clinic and have served as a powerful resource in previous studies (McCarty et al., [@B26]; Cross et al., [@B3]; Hebbring et al., [@B14]). The population of PMRP is stable and highly homogeneous with a predominant Northern European genetic background and so carries lower risk of confounding by population stratification. All individuals in the study provided informed consent and the study was approved by the Marshfield Clinic IRB.

Study design
------------

This study examined host susceptibility genes for *S. aureus* infection regardless of *S. aureus* colonization status. We performed a case/control GWAS on a subgroup of the PMRP population: 3234 subjects (309 cases/2925 controls). All study subjects were over 49 years of age. Cases were defined as individuals who had at least one laboratory confirmed test in their medical record of a disease caused by *S. aureus.* Controls were subjects who did not have any evidence of infection due to *S. aureus* in their EMR. We reasoned that because cases had to have evidence of laboratory confirmed *S. aureus* infection in the EMR, patients with no evidence of infection in the EMR would form an ideal control group. The results using our control group are likely very similar to those that would be obtained using population-based controls, as is often employed in GWAS studies (Burton et al., [@B2]). Only subjects with self-identified Northern European ancestry were included; therefore, both cases and controls had the same genetic ancestry. Additionally, a principal components analysis of their genome-wide genotypes in all study subjects (without knowledge of case/control status) was performed, revealing no evidence of population substructure (Supplemental Figure [1](#SM1){ref-type="supplementary-material"}). With this filtered set of case/control subjects, we performed three levels of statistical analysis: SNP-based, Gene-based, and Pathway-based, to identify novel polymorphisms, genes, and pathways involved in susceptibility to *S. aureus* diseases. This hierarchical investigation of genetic effects allows for the incorporation of a gradation of biological information into the statistical tests---the SNP-based scan is the most comprehensive and agnostic to prior biological knowledge, the gene-based analysis uses positional information and collapses effects from the same protein-coding region, and the pathway-based analysis incorporates information obtained from various molecular biology studies.

Phenotypes
----------

We extracted demographic and medical information on all case/control subjects from the Marshfield Clinic EMR. All cases had an active infection that had yielded *S. aureus* as the major or the only bacterium on a culture plate from a clinical sample such as blood, sputum, etc. Hospital surveillance subjects who were positive for *S. aureus* colonization by PCR were excluded from the study. Age, sex, body mass index (BMI), and Type 2 Diabetes (T2D) status as determined from the EMR were tested for association with case/control status. The binary variables were analyzed using a Fisher\'s exact test, and the continuous variables were analyzed through a two-tailed *T*-test to test mean differences between cases and controls.

Genotypic data
--------------

The Illumina 660W-QUAD Beadchip array (Illumina, San Diego, California, USA) was used to generate genotype data on over 500 K SNPs from cases and controls. To ease automation of analysis, only data obtained from autosomes were analyzed. After filtering out SNPs with low minor allele frequency (\<0.01), missing genotype data (≥0.05 of the study population with missing genotypes) or a significant departure from Hardy-Weinberg equilibrium (HWE) (*p* \< 1E-5), there were 508,921 SNPs that passed the quality control screening and were used in subsequent analysis. For a sample to be included in the analysis, we ensured that it had at least 99% of the non-missing SNPs and for each SNP to be included in the analysis, we required that the SNP should have at least 95% of the non-missing subjects.

Population stratification estimation using EIGENSOFT
----------------------------------------------------

We used the EIGENSOFT program (Price et al., [@B33]) to examine population stratification in our dataset. The program combines population genetics methods and the use of PCA to explicitly capture ancestry differences between cases and controls along continuous axes of variation.

SNP-based analysis using PLINK and R--Package
---------------------------------------------

PLINK (Purcell et al., [@B34]), a whole genome association analysis tool set, was used to perform the filtering and QC procedures (as described under "Genotypic data" above) on the raw dataset to generate the data set employed in this study. R is a free software programming language and software environment for statistical computing and graphics (R. Core Team, [@B35]). The glm() function within R was used to establish the logistic model assuming an additive mode of inheritance with adjustment for the following risk factors: age, gender, BMI, diabetes and the top three principal components estimated from EIGENSOFT for population stratification. The *p*-values calculated from the logistic model were used to test the associations between SNPs and case/control phenotype.

Gene-based analysis using VEGAS
-------------------------------

VEGAS is a software program that tests association between a gene and phenotype trait. VEGAS uses SNP-level data to incorporate information from a full set of markers annotated to each gene and accounts for linkage disequilibrium (LD) between markers (Neale and Sham, [@B29]; Liu et al., [@B24]). All SNPs annotated to a gene were used in the calculation, and the method adjusted by the linkage disequilibrium structure by using HapMap data. Monte Carlo simulations from multivariate Gaussian random variables and Cholesky decomposition matrices were employed by VEGAS to produce disease association *p*-values per gene, correcting for the correlation structure between nearby SNPs. This type of analysis has several advantages including the collapsing of effects for all genotyped SNPs within each gene, and reducing the multiple testing burdens. The LD structure of each gene region is factored into the analysis through applying decomposition matrices in the analysis, effectively factoring-out the correlational structure between tightly linked SNPs. Additionally, gene-based results enable the subsequent use of many pathway analysis packages designed to use a single measurement from each gene.

Pathway-based analysis by DAVID, PANTHER, and ingenuity pathway analysis (IPA) programs
---------------------------------------------------------------------------------------

All genes with a *p*-value = 0.01 from the VEGAS analysis were used as input to perform separate pathway analysis by DAVID, PANTHER, and IPA. The DAVID analyses consisted of three steps: measurement of the functional relationship of gene pairs, a DAVID agglomeration procedure to partition genes into functional gene groups, and visualization of the results (Huang et al., [@B18], [@B16],[@B17]). PANTHER is a publically-available database having gene ontology, functional annotation, and evolutionary conservation information. PANTHER Pathways are available within the database and these pathways were used in our analysis. We calculated *p*-values for enrichment of *S. aureus*-associated genes within specific PANTHER pathways using a standard hypergeometric statistical approach. The statistical over-representation test was implemented in the PANTHER program. A binomial test was used to compare our gene list to a reference list (all human genes) to determine over- or under- representation of genes from our list in PANTHER gene function categories using an experiment-wise approach (experiment-wise α = 0.05) (Mi and Thomas, [@B27]). Gene-based analyses using IPA (Ingenuity® Systems, [www.ingenuity.com](http://www.ingenuity.com), Redwood City, California, USA, [www.ingenuity.com](http://www.ingenuity.com)) were used to generate protein-protein interaction networks.

Results {#s3}
=======

Population stratification
-------------------------

Using EIGENSOFT to perform PCA of the 508,921 genotypes from all study subjects (without knowledge of case/control status), we found no evidence of strong population stratification (Supplemental Figure [1](#SM1){ref-type="supplementary-material"}). Therefore none of the 3234 study subjects were excluded because of population stratification.

Study subject characteristics
-----------------------------

It has been previously noted that male sex, age, high BMI and T2D are risk factors for invasive *S. aureus* infection (Graffunder and Venezia, [@B10]). As expected, the percent of males was significantly greater in the cases than the control group (51 vs. 39%; *p* = 5.50E-05) (Table [1](#T1){ref-type="table"}). There was no significant difference in mean age of case and controls. The prevalence of T2D was significantly higher among cases than controls (22.3 vs. 12.7%; *p* = 1.03E-05) and so was the mean BMI (cases: 32.1 vs. control: 29.5 kg/m^2^; *p* = 3.50E-8). Our findings are consistent with those of previous reports.

###### 

**Demographic and other phenotypic characteristics**.

  **Characteristic**                        **Cases (N = 309)**   **Controls (N = 2925)**   ***p*-value[^\*^](#TN1){ref-type="table-fn"}**
  ----------------------------------------- --------------------- ------------------------- ------------------------------------------------
  Age (years) (mean ± *SD*)                 74.5 ± 10.9           73.5 (10.8)               0.13
  Males (*N*, %)                            159 (51.5)            1153 (39.4)               5.50E-05
  Type 2 diabetes (N, %)                    69 (22.3)             370 (12.7)                1.03E-05
  Body mass index (kg/m^2^) (mean ± *SD*)   32.1 ± 8.0            29.5 ± 6.1                3.50E-08

Two-tailed t-test assuming unequal variances used to compare continuous variables (age and body mass index) and Fisher\'s exact test used to compare categorical variables (% males and % with type 2 diabetes).

Q-Q plot
--------

We performed Q-Q analysis on the *p*-values obtained using logistic model assuming additive model of inheritance (Figure [1](#F1){ref-type="fig"}). The plot showed no evidence of population stratification, confounding effects, or systematic bias in the results from the statistical routines employed.

![**The Q-Q plot of the *p*-values from all 508,921 SNPs**. The x-axis shows the expected −log~10~(*p*-value). The y-axis shows the observed --log~10~(*p*-value).](fgene-05-00125-g0001){#F1}

HWE
---

Eight hundred forty three SNPs were excluded from the analysis due to departure from HWE exceeding α = 1E-05.

SNP-based analyses
------------------

SNP associations were tested using logistic regression analysis after adjusting for risk factors such as age, gender, BMI, diabetes and three principal components. No single SNP in the GWAS reached the level of genome-wide significance (*p* \< 5 × 10^−8^) (Figure [2](#F2){ref-type="fig"}). However, four SNPs exceeded the *p* \< 10^−5^ threshold, including two SNPs (rs2455012 and rs7152530) with a *p* \< 10^−7^ (Table [2](#T2){ref-type="table"}). Out of these four SNPs, two were intronic (*PDE4B* and *TXNRD2*), one was intergenic with respect to *VRK1* and *BCL11B*, and one was in the 3\'UTR of *PNPLA5*. Of the four SNPs on chromosome 14 (Table [2](#T2){ref-type="table"}), rs1892234 was in weak linkage disequilibrium (LD) with the other three SNPs (*r*^2^ \< 0.42) which were in strong LD with each other (*r*^2^ = 0.80). The two SNPs in *XRN1* were in strong LD (*r*^2^ = 0.92), two of the SNPs on chromosome 22 (rs470093 and rs9614174) were in moderate LD (*r*^2^ = 0.49), and the two SNPs on chromosome 19 exhibited low LD (*r*^2^ = 0.09).

![**The manhattan plot of the *p*-values from all 508,921 SNPs**. The x-axis shows the chromosome numbers. The y-axis is the -log~10~ (*p*-value). The blue line is *p*-value of 10^−5^ whereas the red line shows the genome wide significance *p*-value of 5 × 10^−8^.](fgene-05-00125-g0002){#F2}

###### 

**Top 20 SNPs, their chromosomal locations, associated genes, major and minor alleles, minor allele frequency of cases and controls, *p*-value and odds ratio and 95% confidence interval**.

  **db SNP ID**   **Chr**   **Position (hg19)**   **Nearby genes**       **Variant location**   **Major/minor alleles**   **Case MAF[^\*^](#TN2){ref-type="table-fn"}**   **control MAF**   **P-value**   **Odds ratio (95% CI)**
  --------------- --------- --------------------- ---------------------- ---------------------- ------------------------- ----------------------------------------------- ----------------- ------------- -------------------------
  rs2455012       1         66520998              *PDE4B*                Intron                 C/T                       0.090615                                        0.045190          6.68*E*-07    2.17 (1.59, 2.93)
  rs7152530       14        98641215              *VRK1, BCL11B*         Intergenic             G/A                       0.270227                                        0.366746          8.47*E*-07    0.62 (0.51, 0.75)
  rs3804047       22        19879637              *TXNRD2*               Intron                 T/C                       0.368932                                        0.281143          3.32*E*-06    1.52 (1.27, 1.81)
  rs470093        22        44276171              *PNPLA5*               3\' UTR                G/T                       0.211974                                        0.146838          7.19*E*-06    1.63 (1.31, 2.02)
  rs1381281       14        98615771              *VRK1, BCL11B*         Intergenic             A/G                       0.322006                                        0.410024          1.07*E*-05    0.67 (0.56, 0.80)
  rs13107325      4         103188709             *SLC39A8*              Exon 8                 G/A                       0.113269                                        0.065299          1.09*E*-05    1.88 (1.41, 2.47)
  rs1892234       14        98720904              *VRK1, BCL11B*         Intergenic             T/C                       0.364078                                        0.455897          1.38*E*-05    0.68 (0.57, 0.81)
  rs6948646       7         152945284             *ACTR3B, DPP6*         Intergenic             G/A                       0.444984                                        0.362393          1.41*E*-05    1.46 (1.23, 1.73)
  rs1012203       9         104626708             *GRIN3A, CYLC2*        Intergenic             A/G                       0.048544                                        0.104103          1.59*E*-05    0.44 (0.29, 0.62)
  rs987514        14        98628943              *VRK1, BCL11B*         Intergenic             C/T                       0.330097                                        0.415356          1.95*E*-05    0.68 (0.56, 0.81)
  rs11950651      5         103009768             *NUDT12, EFNA5*        Intergenic             C/T                       0.032362                                        0.079829          2.09*E*-05    0.37 (0.22, 0.57)
  rs12160908      22        25928620              *LRP5L, ADRBK2*        Intergenic             C/T                       0.067961                                        0.127401          2.13*E*-05    0.49 (0.35, 0.67)
  rs12696090      3         158669688             *MFSD1, IQCJ-SCHIP1*   Intergenic             G/T                       0.150485                                        0.226635          2.72*E*-05    0.61 (0.48, 0.76)
  rs9614174       22        44082454              *EFCAB6*               Intron                 A/C                       0.215210                                        0.151795          2.78*E*-05    1.56 (1.26, 1.92)
  rs7255123       19        3958397               *DAPK3*                3\' near gene          G/A                       0.263754                                        0.198632          4.11*E*-05    1.51 (1.24, 1.84)
  rs6135407       20        15397676              *MACROD2*              Intron                 C/T                       0.220065                                        0.158858          4.91*E*-05    1.54 (1.25, 1.90)
  rs4807532       19        3928369               *ATCAY*                3\' near gene          G/A                       0.461165                                        0.375897          5.32*E*-05    1.42 (1.20, 1.69)
  rs7643377       3         142114694             *XRN1*                 Intron                 C/T                       0.483819                                        0.400342          5.70*E*-05    1.41 (1.19, 1.67)
  rs2535368       7         83157207              *SEMA3E*               Intron                 G/A                       0.202265                                        0.144494          5.90*E*-05    1.56 (1.25, 1.93)
  rs9867210       3         142132749             *XRN1*                 Intron                 TIC                       0.495146                                        0.411453          6.17*E*-05    1.41 (1.19, 1.67)

Minor allele frequency.

VEGAS-based gene analyses
-------------------------

Table [3](#T3){ref-type="table"} shows the top 15 genes ranked by their *p*-values from the VEGAS analysis and four additional interesting genes that could potentially have a role in *S. aureus*-caused diseases based on their known involvement in immune and inflammatory processes. The topmost hit was *NMRK2* (or *ITGB1BP3*; *p* = 1.20E-05) which encodes nicotinamide riboside kinase 2. Two of the 15 genes also featured in the list from the SNP-based analysis: *DAPK3* (*p* = 5.10E-05) and *XRN1* (*p* = 1.85E-04).

###### 

**Top 15 and four other potentially interesting gene hits from VEGAS gene-based analysis**.

  **Gene**                                         **Number of SNPs**   **Chr**.   **Start position (hg19)**   **End position (hg19)**   ***p*-value**
  ------------------------------------------------ -------------------- ---------- --------------------------- ------------------------- ---------------
  *NMRK2 (ITGB1BP3)*                               20                   19         3933101                     3942414                   1.20E-05
  *DAPK3*                                          18                   19         3958452                     3969827                   5.10E-05
  *NPM3*                                           4                    10         103541082                   103543170                 0.000142
  *EEF2*                                           17                   19         3976054                     3985461                   0.000167
  *XRN1*                                           12                   3          142025449                   142166853                 0.000185
  *CDK7*                                           *11*                 5          68530622                    68573257                  0.000206
  *FBXL4*                                          17                   6          99321601                    99395849                  0.000257
  *ATR*                                            20                   3          142168077                   142297668                 0.000269
  *FGF8*                                           3                    10         103529887                   103535759                 0.000294
  *MRPS36*                                         8                    5          68513573                    68525985                  0.000423
  *CCDC125*                                        *10*                 5          68576519                    68616407                  0.000424
  *ATCAY*                                          33                   19         3880618                     3928080                   0.000571
  *KCNIP2*                                         6                    10         103585731                   103603677                 0.000637
  *MGEA5*                                          6                    10         103544200                   103578222                 0.000654
  *LDOC1L*                                         30                   22         44888450                    44894178                  0.000664
  [^\*^](#TN3){ref-type="table-fn"}*IL1RL2* (75)   60                   2          102803433                   102855811                 0.0031
  [^\*^](#TN3){ref-type="table-fn"}*IL1B* (80)     20                   2          113587337                   113594356                 0.00322
  [^\*^](#TN3){ref-type="table-fn"}*ILIA* (93)     22                   2          113531492                   113542971                 0.00363
  [^\*^](#TN3){ref-type="table-fn"}*IL1R1* (168)   54                   2          102770401                   102796334                 0.00806

Ranks of these genes are mentioned in parenthesis.

Pathway analyses
----------------

The top-ranked 196 genes (*p*-value = 0.01) resulting from the VEGAS analysis were selected for the DAVID analyses but none of the gene groups were statistically significant. One of the top gene groups (gene group 1; Supplemental Table [1](#SM3){ref-type="supplementary-material"}) included *CST8* (cystatin 8), *SERPINA6* (serine peptidase inhibitor, clade A, member 6), *SERPINA10* (serine peptidase inhibitor, clade A, member 10), and *SPINK1* (serine peptidase inhibitor, Kazak type 1). The enriched genes in group 2 (Supplemental Table [1](#SM3){ref-type="supplementary-material"}) included four keratin genes: *KRT24* (form intermediate filament), *KRT82* (type II hair keratin), *KRT12* (type I intermediate filament keratin 12), and *KRT75* (form intermediate filament in in the cytoplasm of epithelial cells). As expected, the PANTHER analysis also suggested enrichment for intermediate filament cytoskeleton pathway (Supplemental Table [2](#SM4){ref-type="supplementary-material"}). Using the same gene set input as in DAVID and PANTHER, the IPA was also explored with the intent of hypothesis-generating protein-protein interaction networks associated our gene data set. The IPA yielded 12 protein networks (data not shown) of which network 7, involving cell death, and survival, appeared interesting (Supplemental Figure [2](#SM2){ref-type="supplementary-material"}).

Discussion {#s4}
==========

Multiple diseases (endocarditis, skin infections, etc.) caused by *S. aureus* are mediated by two main classes of virulence factors, adhesion and secretory proteins, which interact with host receptors and inflammatory/anti-inflammatory molecules to produce the disease phenotype (Gordon and Lowy, [@B9]). Adhesion proteins help the pathogen to attach to the skin and survive on the epidermis and in the sub-epidermal layer through a repertoire of molecules collectively known as MSCRAMMS (microbial surface components recognizing adhesive matrix molecules). The MSCRAMMS can bind to fibronectin, fibrinogen, and platelets among others. Subsequent to attachment, *S. aureus* can secrete tissue and organ-specific virulence proteins (e.g., coagulase, proteases, toxins, superantigens) with a wide range of virulence functions that enable the pathogen to infect its host.

So far, most of the genetic susceptibility data related to *S. aureus* has been limited to *S. aureus* colonization. For example, the glucocorticoid receptor gene polymorphisms are associated with carriage risk (van den Akker et al., [@B40]), whereas *DEFB1* has been shown to promote persistent colonization by modulating beta-defensin expression in keratinocytes (Nurjadi et al., [@B32]). In contrast, the Danish middle-aged/elderly twin study showed that host genetics had a modest influence only on *S. aureus* carrier state (Andersen et al., [@B1]). While our manuscript was under review, a study by Nelson et al did not find any SNP that has genome wide significance for association with *S. aureus* bacteremia (SAB) although an intronic SNP in *CDON* was speculated to be associated with complicated SAB (Nelson et al., [@B31]). In a report by Stappers et al., four SNPs from three toll-like receptor (*TLR*) genes, *TLR1, TLR2*, and *TLR6*, increase the susceptibility to complicated skin and soft tissue infections caused by staphylococci, streptococci, and enterococci (Stappers et al., [@B37]).

In our multi-tiered GWAS-based investigation, we have identified a number of potentially interesting genes that need further investigation. Although the individual SNP results did not pass genome-wide significance, the top-tier SNPs, Gene-based, and Pathway-based results were enriched for genes that have plausible functions in bacterial infections. This includes genes that have roles in intracellular signaling, inflammation, zinc transport, and integrin binding. Thus, these genes have relatively high prior probabilities for involvement in *S. aureus* infection susceptibility---an aspect of the results that we believe supports considerable interest in subsequent studies to follow-up on these findings.

Notably, two genes (*DAPK3* and *XRN1*) were identified in both the SNP-based and gene-based analyses. *DAPK3* is a protein kinase that modulates apoptosis-related signaling pathways (Wu et al., [@B42]) and, in interaction with *RhoD*, modulates actin filament assembly and focal adhesion reorganization (Nehru et al., [@B30]). *S. aureus* is known to induce apoptosis of host cells during host invasion, leading to a compromised host immune response (Haslinger-Löffler et al., [@B13]). *XRN1* encodes a 5\'--3\' exonuclease family member involved in cellular mRNA turnover (Nagarajan et al., [@B28]). The gene is shown to complete host mRNA degradation initiated by viral pathogens (Gaglia et al., [@B7]). These functions suggest possible roles for *DAPK3* and *XRN1* in susceptibility to diseases caused by *S. aureus*.

Some of the other genes we identified have been implicated in infectious disease processes. *PDE4B* is involved in modulating bacteria-induced inflammation (Komatsu et al., [@B22]). *PNPLA5* appears to be critical for autophagosome functions, including microbial clearance (Dupont et al., [@B5]). Mammalian hosts are known to reduce the level of free zinc to thwart pathogen growth (Kehl-Fie and Skaar, [@B21]) and it is plausible that *SLC39A8*, a zinc transporter, could be involved. *BCL11B* encodes a transcriptional repressor involved in T-cell development (Wakabayashi et al., [@B41]). *NMRK2*, an integrin beta1 binding protein, could function in host responses to bacterial function based on the finding that host fibronectin forms a bridge between *S. aureus* fibronectin-binding proteins and host cell beta1 integrins during *S. aureus* cellular invasion (Fowler et al., [@B6]). Keratin intermediate filaments are shown to have a protective role during infection with *Bartonella henselae* in cat scratch disease (Zhu et al., [@B45]). Interleukin 1 cytokine family members (*IL1A, IL1B, IL1R1*, and *IL1RL2*) are known mediators of immune and inflammatory responses (Garlanda et al., [@B8]).

It is known that many Mendelian and oligogenetic immunodeficiency disorders confer risk to staphylococcal infection including lymphocyte deficiencies such as severe combined immunodeficiency, chronic granulomatous disease, and hyper-IgE syndrome (Stephan et al., [@B38]; Grimbacher et al., [@B12]; Van de Vosse et al., [@B39]). These disorders are typified by highly disruptive mutations occurring in genes central to lymphoid cell competency including *STAT3, JAK3, DOCK8*, and *CD18*, among others (Hogg et al., [@B15]; Kalman et al., [@B20]; Jiao et al., [@B19]; Zhang et al., [@B44]). However, most cases of severe staphylococcal infection are not attributable to these more rare conditions and have unknown genetic etiology.

In summary, this preliminary GWAS applied a SNP-to-gene-to-disease-pathway approach to identify susceptibility genes against a broad umbrella of laboratory confirmed *S. aureus* infections. While no one SNP and gene was found to be highly significant in this study, we suspect that for a versatile pathogen like *S. aureus*, that needs to overcome barriers presented by a variety of tissues and defense systems to infect various sites in the body, there are bound to be several genes involved in host susceptibility. Not everyone exposed to a virulent or a colonizing strain of *S. aureus* has similar severity of infection. It is reasonable to speculate that effects of variants segregating at multiple genes contribute to the severity of *S. aureus* infection. Similarly, there could be protective alleles that may lower the risk of clinically-attended infection as well. Additional studies will be needed to confirm these findings but eventually functional studies will be needed to illuminate the detailed mechanisms of how these variants confer predisposition to infection. Once consensus disease loci and pathways are identified, they can serve as targets for future pharmaceutical development and further elucidation of how aberrant cellular processes/signaling give rise to *Staphylococcus*-induced pathologies.
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###### 

**A principal components analysis of genome-wide genotypes in all study subjects**.

###### 

Click here for additional data file.

###### 

**One of the IPA outputs of the protein-protein interaction network using VEGAS based 196 genes (p ≤ 0.01) as input**. Three genes, *DAPK3, KRT12*, and *TXNRD2* have been shown to be in direct network UBC (ubiquitin C). Boxes in pink color are input genes from the VEGAS analysis. Network shapes Symbols: ⋄ = enzyme; ∘ = Other; ▽ = Kinase; ^\_\_\_^ = direct interaction; \-\-\-\-- = indirect interaction. Additional details about the symbols can be found at [www.ingenuity.com](http://www.ingenuity.com).

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.
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